PATENT CLAIM ANALYSIS

Application Number: 15758548
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "060000"]

Abstract:
The present invention provides compositions and formulations capable of maintaining or promoting the growth of certain strains of  Lactobacilli  spp. The compositions and formulations generally comprise only a single therapeutic agent selected from the group consisting of isomaltulose, maltitol, pullulan, maltotriose, 2-deoxy-D-ribose, 1-kestose and erlose. The single therapeutic agent is the sole source of carbon for bacterium when administered to a user. Despite comprising only a single therapeutic agent the compositions have been shown to promote the growth and maintenance of beneficial  lactobacilli  and to effectively inhibit the growth of pathogens associated with urogenital infections. As such administration of the compositions maintain a healthy microflora balance in the urogenital area.

Claim (Index 8):
The pharmaceutical formulation of  claim 7  wherein the single therapeutic agent comprises from about 0.1 to about 2.0 wt/vol %.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.64384
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11194064', '13224480', '15291880', '12634504', '10490022']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7711085835007615
- 35 USC 102 Novelty (BERT): 0.4833978011226628
- Combined Prediction Score: 0.7423375052629516
- Mean Citation Score: 166.189348
- Max Citation Score: 191.31079
- Similarity Product: 140.9683407222402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test